{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:18:02Z","timestamp":1792678682312,"version":"4.5.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s10048-016-0478-0","type":"journal-article","created":{"date-parts":[[2016,3,6]],"date-time":"2016-03-06T21:22:31Z","timestamp":1457299351000},"page":"145-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Up-regulation of SNCA gene expression: implications to synucleinopathies"],"prefix":"10.1007","volume":"17","author":[{"given":"L.","family":"Tagliafierro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Chiba-Falek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"key":"478_CR1","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","volume":"90","author":"K Ueda","year":"1993","unstructured":"Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 90:11282\u201311286","journal-title":"Proc Natl Acad Sci U S A"},{"key":"478_CR2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","volume":"58","author":"JE Galvin","year":"2001","unstructured":"Galvin JE, Lee VM, Trojanowski JQ (2001) Synucleinopathies: clinical and pathological implications. Arch Neurol 58:186\u2013190","journal-title":"Arch Neurol"},{"issue":"Suppl 6","key":"478_CR3","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/mds.10559","volume":"18","author":"MJ Marti","year":"2003","unstructured":"Marti MJ, Tolosa E, Campdelacreu J (2003) Clinical overview of the synucleinopathies. Mov Disord 18(Suppl 6):S21\u2013S27. doi: 10.1002\/mds.10559","journal-title":"Mov Disord"},{"key":"478_CR4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1353-8020(99)00031-0","volume":"5","author":"MG Spillantini","year":"1999","unstructured":"Spillantini MG (1999) Parkinson\u2019s disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies. Parkinsonism Relat Disord 5:157\u2013162","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 6","key":"478_CR5","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1002\/mds.10557","volume":"18","author":"KA Jellinger","year":"2003","unstructured":"Jellinger KA (2003) Neuropathological spectrum of synucleinopathies. Mov Disord 18(Suppl 6):S2\u201312. doi: 10.1002\/mds.10557","journal-title":"Mov Disord"},{"key":"478_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1385\/1-59259-142-6:33","volume":"62","author":"M Goedert","year":"2001","unstructured":"Goedert M, Jakes R, Anthony Crowther R, Grazia Spillantini M (2001) Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy as alpha-synucleinopathies. Methods Mol Med 62:33\u201359. doi: 10.1385\/1-59259-142-6:33","journal-title":"Methods Mol Med"},{"key":"478_CR7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"478_CR8","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"478_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/ajmg.b.32288","volume":"168B","author":"W Han","year":"2015","unstructured":"Han W, Liu Y, Mi Y, Zhao J, Liu D, Tian Q (2015) Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson\u2019s disease: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 168B:123\u2013134. doi: 10.1002\/ajmg.b.32288","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"478_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00439-008-0582-9","volume":"124","author":"N Pankratz","year":"2009","unstructured":"Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, Pugh EW, Doheny KF, Gusella JF, Nichols WC, Foroud T, Myers RH, Psg P, GenePd Investigators C, Molecular Genetic L (2009) Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 124:593\u2013605. doi: 10.1007\/s00439-008-0582-9","journal-title":"Hum Genet"},{"key":"478_CR11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-0404.2008.01019.x","volume":"118","author":"R Myhre","year":"2008","unstructured":"Myhre R, Toft M, Kachergus J, Hulihan MM, Aasly JO, Klungland H, Farrer MJ (2008) Multiple alpha-synuclein gene polymorphisms are associated with Parkinson\u2019s disease in a Norwegian population. Acta Neurol Scand 118:320\u2013327","journal-title":"Acta Neurol Scand"},{"key":"478_CR12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.mad.2007.04.002","volume":"128","author":"OA Ross","year":"2007","unstructured":"Ross OA, Gosal D, Stone JT, Lincoln SJ, Heckman MG, Irvine GB, Johnston JA, Gibson JM, Farrer MJ, Lynch T (2007) Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson\u2019s disease. Mech Ageing Dev 128:378\u2013382","journal-title":"Mech Ageing Dev"},{"key":"478_CR13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20268","volume":"56","author":"P Pals","year":"2004","unstructured":"Pals P, Lincoln S, Manning J, Heckman M, Skipper L, Hulihan M, Van den Broeck M, De Pooter T, Cras P, Crook J, Van Broeckhoven C, Farrer MJ (2004) Alpha-synuclein promoter confers susceptibility to Parkinson\u2019s disease. Ann Neurol 56:591\u2013595","journal-title":"Ann Neurol"},{"key":"478_CR14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.20438","volume":"57","author":"JC Mueller","year":"2005","unstructured":"Mueller JC, Fuchs J, Hofer A, Zimprich A, Lichtner P, Illig T, Berg D, Wullner U, Meitinger T, Gasser T (2005) Multiple regions of alpha-synuclein are associated with Parkinson\u2019s disease. Ann Neurol 57:535\u2013541","journal-title":"Ann Neurol"},{"key":"478_CR15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/hmg\/ddl030","volume":"15","author":"I Mizuta","year":"2006","unstructured":"Mizuta I, Satake W, Nakabayashi Y, Ito C, Suzuki S, Momose Y, Nagai Y, Oka A, Inoko H, Fukae J, Saito Y, Sawabe M, Murayama S, Yamamoto M, Hattori N, Murata M, Toda T (2006) Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson\u2019s disease. Hum Mol Genet 15:1151\u20131158","journal-title":"Hum Mol Genet"},{"key":"478_CR16","doi-asserted-by":"crossref","unstructured":"Winkler S, Hagenah J, Lincoln S, Heckman M, Haugarvoll K, Lohmann-Hedrich K, Kostic V, Farrer M, Klein C (2007) {alpha}-synuclein and Parkinson disease susceptibility. Neurology 69:1745\u201350","DOI":"10.1212\/01.wnl.0000275524.15125.f4"},{"key":"478_CR17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","volume":"41","author":"W Satake","year":"2009","unstructured":"Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T, Watanabe M, Takeda A, Tomiyama H, Nakashima K, Hasegawa K, Obata F, Yoshikawa T, Kawakami H, Sakoda S, Yamamoto M, Hattori N, Murata M, Nakamura Y, Toda T (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease. Nat Genet 41:1303\u20131307","journal-title":"Nat Genet"},{"key":"478_CR18","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Kruger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T (2009) Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet 41:1308\u20131312","journal-title":"Nat Genet"},{"key":"478_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.2009.00560.x","author":"TL Edwards","year":"2010","unstructured":"Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, Wang L, Zuchner S, Konidari I, Wang G, Singer C, Nahab F, Scott B, Stajich JM, Pericak-Vance M, Haines J, Vance JM, Martin ER (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet. doi: 10.1111\/j.1469-1809.2009.00560.x","journal-title":"Ann Hum Genet"},{"key":"478_CR20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.296.6.661","volume":"296","author":"DM Maraganore","year":"2006","unstructured":"Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Kruger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C (2006) Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. Jama 296:661\u2013670","journal-title":"Jama"},{"key":"478_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/hmg\/ddq469","volume":"20","author":"S CC","year":"2010","unstructured":"CC S, Plagnol V, Strange A, Gardner M, Paisan-Ruiz C, Band G, RA B, Bellenguez C, Bhatia K, Blackburn H, JM B, Bramon E, MA B, Burn D, JP C, PF C, CE C, Corvin A, Craddock N, Deloukas P, Edkins S, Evans J, Freeman C, Gray E, Hardy J, Hudson G, Hunt S, Jankowski J, Langford C, AJ L, HS M, CG M, MI MC, KE M, CN P, JP P, Peltonen L, Pirinen M, Plomin R, Potter S, Rautanen A, SJ S, Z S, RC T, AC V, NW W, HR M, Donnelly P, NW W (2010) Dissection of the genetics of Parkinson\u2019s disease identifies an additional association 5\u2019 of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet 20:345\u2013353. doi: 10.1093\/hmg\/ddq469","journal-title":"Hum Mol Genet"},{"key":"478_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2010.254","author":"J Simon-Sanchez","year":"2011","unstructured":"Simon-Sanchez J, van Hilten JJ, van de Warrenburg B, Post B, Berendse HW, Arepalli S, Hernandez DG, de Bie RM, Velseboer D, Scheffer H, Bloem B, van Dijk KD, Rivadeneira F, Hofman A, Uitterlinden AG, Rizzu P, Bochdanovits Z, Singleton AB, Heutink P (2011) Genome-wide association study confirms extant PD risk loci among the Dutch. Eur J Hum Genet. doi: 10.1038\/ejhg.2010.254","journal-title":"Eur J Hum Genet"},{"key":"478_CR23","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/archneurol.2010.279","volume":"67","author":"IF Mata","year":"2010","unstructured":"Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, Samii A, Snapinn KW, Tsuang DW, Yearout D, Zhang J, Payami H, Zabetian CP (2010) SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch Neurol 67:1350\u20131356. doi: 10.1001\/archneurol.2010.279","journal-title":"Arch Neurol"},{"key":"478_CR24","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","volume":"23","author":"J Bras","year":"2014","unstructured":"Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S, Dickson DW, Singleton A, Hardy J (2014) Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet 23:6139\u20136146. doi: 10.1093\/hmg\/ddu334","journal-title":"Hum Mol Genet"},{"key":"478_CR25","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.21685","volume":"65","author":"SW Scholz","year":"2009","unstructured":"Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wullner U, Goldwurm S, Pellecchia MT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, Poewe W, Wenning GK, Hardy JA, Singleton AB, Gasser T (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 65:610\u2013614","journal-title":"Ann Neurol"},{"key":"478_CR26","doi-asserted-by":"publisher","first-page":"e7114","DOI":"10.1371\/journal.pone.0007114","volume":"4","author":"Al-Chalabi A, Durr A, Wood NW, Parkinson MH, Camuzat A, Hulot JS, Morrison KE, Renton A, Sussmuth SD, Landwehrmeyer BG, Ludolph A, Agid Y, Brice A, Leigh PN, Bensimon G, Group NGS","year":"2009","unstructured":"Al-Chalabi A, Durr A, Wood NW, Parkinson MH, Camuzat A, Hulot JS, Morrison KE, Renton A, Sussmuth SD, Landwehrmeyer BG, Ludolph A, Agid Y, Brice A, Leigh PN, Bensimon G, Group NGS (2009) Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS one 4:e7114. doi: 10.1371\/journal.pone.0007114","journal-title":"PLoS one"},{"key":"478_CR27","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1093\/hmg\/ddu196","volume":"23","author":"C Linnertz","year":"2014","unstructured":"Linnertz C, Lutz MW, Ervin JF, Allen J, Miller NR, Welsh-Bohmer KA, Roses AD, Chiba-Falek O (2014) The genetic contributions of SNCA and LRRK2 genes to Lewy body pathology in Alzheimer\u2019s disease. Hum Mol Genet 23:4814\u20134821. doi: 10.1093\/hmg\/ddu196","journal-title":"Hum Mol Genet"},{"key":"478_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.05.011","author":"MW Lutz","year":"2015","unstructured":"Lutz MW, Saul R, Linnertz C, Glenn OC, Roses AD, Chiba-Falek O (2015) A cytosine-thymine (CT)-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer\u2019s disease and affects SNCA expression. Alzheimer\u2019s Dementia: J Alzheimer\u2019s Assoc. doi: 10.1016\/j.jalz.2015.05.011","journal-title":"Alzheimer\u2019s Dementia: J Alzheimer\u2019s Assoc"},{"key":"478_CR29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18:106\u2013108","journal-title":"Nat Genet"},{"key":"478_CR30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164\u2013173","journal-title":"Ann Neurol"},{"key":"478_CR31","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841","journal-title":"Science"},{"key":"478_CR32","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/hmg\/9.18.2683","volume":"9","author":"SJ Tabrizi","year":"2000","unstructured":"Tabrizi SJ, Orth M, Wilkinson JM, Taanman JW, Warner TT, Cooper JM, Schapira AH (2000) Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity. Hum Mol Genet 9:2683\u20132689","journal-title":"Hum Mol Genet"},{"key":"478_CR33","doi-asserted-by":"publisher","first-page":"878935","DOI":"10.1155\/2014\/878935","volume":"2014","author":"K Banerjee","year":"2014","unstructured":"Banerjee K, Munshi S, Sen O, Pramanik V, Roy Mukherjee T, Chakrabarti S (2014) Dopamine cytotoxicity involves both oxidative and nonoxidative pathways in SH-SY5Y cells: potential role of alpha-synuclein overexpression and proteasomal inhibition in the etiopathogenesis of Parkinson\u2019s disease. Parkinsons Dis 2014:878935. doi: 10.1155\/2014\/878935","journal-title":"Parkinsons Dis"},{"key":"478_CR34","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1471-4159.2009.06054.x","volume":"109","author":"K Vekrellis","year":"2009","unstructured":"Vekrellis K, Xilouri M, Emmanouilidou E, Stefanis L (2009) Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death. J Neurochem 109:1348\u20131362. doi: 10.1111\/j.1471-4159.2009.06054.x","journal-title":"J Neurochem"},{"key":"478_CR35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0006-8993(00)02215-0","volume":"866","author":"W Zhou","year":"2000","unstructured":"Zhou W, Hurlbert MS, Schaack J, Prasad KN, Freed CR (2000) Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res 866:33\u201343","journal-title":"Brain Res"},{"key":"478_CR36","doi-asserted-by":"publisher","first-page":"e89327","DOI":"10.1371\/journal.pone.0089327","volume":"9","author":"K Taguchi","year":"2014","unstructured":"Taguchi K, Watanabe Y, Tsujimura A, Tatebe H, Miyata S, Tokuda T, Mizuno T, Tanaka M (2014) Differential expression of alpha-synuclein in hippocampal neurons. PLoS one 9:e89327. doi: 10.1371\/journal.pone.0089327","journal-title":"PLoS one"},{"key":"478_CR37","doi-asserted-by":"publisher","first-page":"e1811","DOI":"10.1038\/cddis.2015.169","volume":"6","author":"JC Koch","year":"2015","unstructured":"Koch JC, Bitow F, Haack J, d\u2019Hedouville Z, Zhang JN, Tonges L, Michel U, Oliveira LM, Jovin TM, Liman J, Tatenhorst L, Bahr M, Lingor P (2015) Alpha-synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons. Cell Death Dis 6:e1811. doi: 10.1038\/cddis.2015.169","journal-title":"Cell Death Dis"},{"key":"478_CR38","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1096\/fj.02-0041fje","volume":"16","author":"JH Seo","year":"2002","unstructured":"Seo JH, Rah JC, Choi SH, Shin JK, Min K, Kim HS, Park CH, Kim S, Kim EM, Lee SH, Lee S, Suh SW, Suh YH (2002) Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3\/Akt kinase pathway. FASEB J 16:1826\u20131828. doi: 10.1096\/fj.02-0041fje","journal-title":"FASEB J"},{"key":"478_CR39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/nm0602-600","volume":"8","author":"J Xu","year":"2002","unstructured":"Xu J, Kao SY, Lee FJ, Song W, Jin LW, Yankner BA (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med 8:600\u2013606. doi: 10.1038\/nm0602-600","journal-title":"Nat Med"},{"key":"478_CR40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0304-3940(02)00016-2","volume":"320","author":"E Junn","year":"2002","unstructured":"Junn E, Mouradian MM (2002) Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. Neurosci Lett 320:146\u2013150","journal-title":"Neurosci Lett"},{"key":"478_CR41","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.neurobiolaging.2014.02.028","volume":"35","author":"VE May","year":"2014","unstructured":"May VE, Ettle B, Poehler AM, Nuber S, Ubhi K, Rockenstein E, Winner B, Wegner M, Masliah E, Winkler J (2014) Alpha-synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy. Neurobiol Aging 35:2357\u20132368. doi: 10.1016\/j.neurobiolaging.2014.02.028","journal-title":"Neurobiol Aging"},{"key":"478_CR42","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ncomms1453","volume":"2","author":"MJ Devine","year":"2011","unstructured":"Devine MJ, Ryten M, Vodicka P, Thomson AJ, Burdon T, Houlden H, Cavaleri F, Nagano M, Drummond NJ, Taanman JW, Schapira AH, Gwinn K, Hardy J, Lewis PA, Kunath T (2011) Parkinson\u2019s disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat Commun 2:440. doi: 10.1038\/ncomms1453","journal-title":"Nat Commun"},{"key":"478_CR43","doi-asserted-by":"publisher","first-page":"e26159","DOI":"10.1371\/journal.pone.0026159","volume":"6","author":"B Byers","year":"2011","unstructured":"Byers B, Cord B, Nguyen HN, Schule B, Fenno L, Lee PC, Deisseroth K, Langston JW, Pera RR, Palmer TD (2011) SNCA triplication Parkinson\u2019s patient\u2019s iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress. PLoS one 6:e26159. doi: 10.1371\/journal.pone.0026159","journal-title":"PLoS one"},{"key":"478_CR44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11910-012-0270-y","volume":"12","author":"B Byers","year":"2012","unstructured":"Byers B, Lee HL, Reijo Pera R (2012) Modeling Parkinson\u2019s disease using induced pluripotent stem cells. Current Neurol Neurosci Rep 12:237\u2013242. doi: 10.1007\/s11910-012-0270-y","journal-title":"Current Neurol Neurosci Rep"},{"key":"478_CR45","doi-asserted-by":"publisher","first-page":"e112413","DOI":"10.1371\/journal.pone.0112413","volume":"9","author":"A Flierl","year":"2014","unstructured":"Flierl A, Oliveira LM, Falomir-Lockhart LJ, Mak SK, Hesley J, Soldner F, Arndt-Jovin DJ, Jaenisch R, Langston JW, Jovin TM, Schule B (2014) Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication. PLoS one 9:e112413. doi: 10.1371\/journal.pone.0112413","journal-title":"PLoS one"},{"key":"478_CR46","doi-asserted-by":"publisher","first-page":"e1994","DOI":"10.1038\/cddis.2015.318","volume":"6","author":"LM Oliveira","year":"2015","unstructured":"Oliveira LM, Falomir-Lockhart LJ, Botelho MG, Lin KH, Wales P, Koch JC, Gerhardt E, Taschenberger H, Outeiro TF, Lingor P, Schule B, Arndt-Jovin DJ, Jovin TM (2015) Elevated alpha-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson\u2019s patient-derived induced pluripotent stem cells. Cell Death Dis 6:e1994. doi: 10.1038\/cddis.2015.318","journal-title":"Cell Death Dis"},{"key":"478_CR47","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.stemcr.2015.07.002","volume":"5","author":"M Djelloul","year":"2015","unstructured":"Djelloul M, Holmqvist S, Boza-Serrano A, Azevedo C, Yeung MS, Goldwurm S, Frisen J, Deierborg T, Roybon L (2015) Alpha-synuclein expression in the oligodendrocyte lineage: an in vitro and in vivo study using rodent and human models. Stem Cell Reports 5:174\u2013184. doi: 10.1016\/j.stemcr.2015.07.002","journal-title":"Stem Cell Reports"},{"key":"478_CR48","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.scr.2013.08.002","volume":"11","author":"LA Crompton","year":"2013","unstructured":"Crompton LA, Byrne ML, Taylor H, Kerrigan TL, Bru-Mercier G, Badger JL, Barbuti PA, Jo J, Tyler SJ, Allen SJ, Kunath T, Cho K, Caldwell MA (2013) Stepwise, non-adherent differentiation of human pluripotent stem cells to generate basal forebrain cholinergic neurons via hedgehog signaling. Stem Cell Res 11:1206\u20131221. doi: 10.1016\/j.scr.2013.08.002","journal-title":"Stem Cell Res"},{"key":"478_CR49","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/emmm.201200215","volume":"4","author":"A Sanchez-Danes","year":"2012","unstructured":"Sanchez-Danes A, Richaud-Patin Y, Carballo-Carbajal I, Jimenez-Delgado S, Caig C, Mora S, Di Guglielmo C, Ezquerra M, Patel B, Giralt A, Canals JM, Memo M, Alberch J, Lopez-Barneo J, Vila M, Cuervo AM, Tolosa E, Consiglio A, Raya A (2012) Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson\u2019s disease. EMBO Mol Med 4:380\u2013395. doi: 10.1002\/emmm.201200215","journal-title":"EMBO Mol Med"},{"key":"478_CR50","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.arr.2012.02.001","volume":"12","author":"AA Moskalev","year":"2013","unstructured":"Moskalev AA, Shaposhnikov MV, Plyusnina EN, Zhavoronkov A, Budovsky A, Yanai H, Fraifeld VE (2013) The role of DNA damage and repair in aging through the prism of Koch-like criteria. Ageing Res Rev 12:661\u2013684. doi: 10.1016\/j.arr.2012.02.001","journal-title":"Ageing Res Rev"},{"key":"478_CR51","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/35041687","volume":"408","author":"T Finkel","year":"2000","unstructured":"Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239\u2013247. doi: 10.1038\/35041687","journal-title":"Nature"},{"key":"478_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s13311-013-0234-1","volume":"11","author":"W Le","year":"2014","unstructured":"Le W, Sayana P, Jankovic J (2014) Animal models of Parkinson\u2019s disease: a gateway to therapeutics? Neurotherapeutics 11:92\u2013110. doi: 10.1007\/s13311-013-0234-1","journal-title":"Neurotherapeutics"},{"key":"478_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.arr.2014.04.002","volume":"15","author":"H Deng","year":"2014","unstructured":"Deng H, Yuan L (2014) Genetic variants and animal models in SNCA and Parkinson disease. Ageing Res Rev 15:161\u2013176. doi: 10.1016\/j.arr.2014.04.002","journal-title":"Ageing Res Rev"},{"key":"478_CR54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1471-4159.2003.01809.x","volume":"86","author":"M Lakso","year":"2003","unstructured":"Lakso M, Vartiainen S, Moilanen AM, Sirvio J, Thomas JH, Nass R, Blakely RD, Wong G (2003) Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J Neurochem 86:165\u2013172","journal-title":"J Neurochem"},{"key":"478_CR55","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","volume":"404","author":"MB Feany","year":"2000","unstructured":"Feany MB, Bender WW (2000) A Drosophila model of Parkinson\u2019s disease. Nature 404:394\u2013398","journal-title":"Nature"},{"key":"478_CR56","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","volume":"91","author":"M Yamada","year":"2004","unstructured":"Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H (2004) Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson\u2019s disease. J Neurochem 91:451\u2013461. doi: 10.1111\/j.1471-4159.2004.02728.x","journal-title":"J Neurochem"},{"key":"478_CR57","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/brain\/aws358","volume":"136","author":"S Nuber","year":"2013","unstructured":"Nuber S, Harmuth F, Kohl Z, Adame A, Trejo M, Schonig K, Zimmermann F, Bauer C, Casadei N, Giel C, Calaminus C, Pichler BJ, Jensen PH, Muller CP, Amato D, Kornhuber J, Teismann P, Yamakado H, Takahashi R, Winkler J, Masliah E, Riess O (2013) A progressive dopaminergic phenotype associated with neurotoxic conversion of alpha-synuclein in BAC-transgenic rats. Brain 136:412\u2013432. doi: 10.1093\/brain\/aws358","journal-title":"Brain"},{"key":"478_CR58","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287:1265\u20131269","journal-title":"Science"},{"key":"478_CR59","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.mcn.2011.11.006","volume":"49","author":"JR McLean","year":"2012","unstructured":"McLean JR, Hallett PJ, Cooper O, Stanley M, Isacson O (2012) Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson\u2019s disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression. Mol Cell Neurosci 49:230\u2013239. doi: 10.1016\/j.mcn.2011.11.006","journal-title":"Mol Cell Neurosci"},{"key":"478_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.nbd.2014.06.017","volume":"70","author":"SR Subramaniam","year":"2014","unstructured":"Subramaniam SR, Vergnes L, Franich NR, Reue K, Chesselet MF (2014) Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein. Neurobiol Dis 70:204\u2013213. doi: 10.1016\/j.nbd.2014.06.017","journal-title":"Neurobiol Dis"},{"key":"478_CR61","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","volume":"26","author":"PM Keeney","year":"2006","unstructured":"Keeney PM, Xie J, Capaldi RA, Bennett JP Jr (2006) Parkinson\u2019s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26:5256\u20135264. doi: 10.1523\/JNEUROSCI.0984-06.2006","journal-title":"J Neurosci"},{"key":"478_CR62","doi-asserted-by":"publisher","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","volume":"110","author":"S Janezic","year":"2013","unstructured":"Janezic S, Threlfell S, Dodson PD, Dowie MJ, Taylor TN, Potgieter D, Parkkinen L, Senior SL, Anwar S, Ryan B, Deltheil T, Kosillo P, Cioroch M, Wagner K, Ansorge O, Bannerman DM, Bolam JP, Magill PJ, Cragg SJ, Wade-Martins R (2013) Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc Natl Acad Sci U S A 110:E4016\u2013E4025. doi: 10.1073\/pnas.1309143110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"478_CR63","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","volume":"45","author":"I Yazawa","year":"2005","unstructured":"Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K, Trojanowski JQ, Lee VM (2005) Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45:847\u2013859. doi: 10.1016\/j.neuron.2005.01.032","journal-title":"Neuron"},{"key":"478_CR64","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","volume":"166","author":"N Stefanova","year":"2005","unstructured":"Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, Wenning GK (2005) Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol 166:869\u2013876","journal-title":"Am J Pathol"},{"key":"478_CR65","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1073\/pnas.0536383100","volume":"100","author":"D Kirik","year":"2003","unstructured":"Kirik D, Annett LE, Burger C, Muzyczka N, Mandel RJ, Bjorklund A (2003) Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 100:2884\u20132889. doi: 10.1073\/pnas.0536383100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"478_CR66","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","volume":"68","author":"J Fuchs","year":"2007","unstructured":"Fuchs J, Nilsson C, Kachergus J, Munz M, Larsson EM, Schule B, Langston JW, Middleton FA, Ross OA, Hulihan M, Gasser T, Farrer MJ (2007) Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 68:916\u2013922","journal-title":"Neurology"},{"key":"478_CR67","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.21380","volume":"63","author":"OA Ross","year":"2008","unstructured":"Ross OA, Braithwaite AT, Skipper LM, Kachergus J, Hulihan MM, Middleton FA, Nishioka K, Fuchs J, Gasser T, Maraganore DM, Adler CH, Larvor L, Chartier-Harlin MC, Nilsson C, Langston JW, Gwinn K, Hattori N, Farrer MJ (2008) Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol 63:743\u2013750","journal-title":"Ann Neurol"},{"key":"478_CR68","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364:1167\u20131169","journal-title":"Lancet"},{"key":"478_CR69","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","volume":"364","author":"P Ibanez","year":"2004","unstructured":"Ibanez P, Bonnet AM, Debarges B, Lohmann E, Tison F, Pollak P, Agid Y, Durr A, Brice A (2004) Causal relation between alpha-synuclein gene duplication and familial Parkinson\u2019s disease. Lancet 364:1169\u20131171","journal-title":"Lancet"},{"key":"478_CR70","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","volume":"55","author":"M Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55:174\u2013179","journal-title":"Ann Neurol"},{"key":"478_CR71","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1212\/01.WNL.0000127517.33208.F4","volume":"62","author":"DW Miller","year":"2004","unstructured":"Miller DW, Hague SM, Clarimon J, Baptista M, Gwinn-Hardy K, Cookson MR, Singleton AB (2004) Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62:1835\u20131838","journal-title":"Neurology"},{"key":"478_CR72","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/mds.21007","volume":"21","author":"O Chiba-Falek","year":"2006","unstructured":"Chiba-Falek O, Lopez GJ, Nussbaum RL (2006) Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov Disord 21:1703\u20131708. doi: 10.1002\/mds.21007","journal-title":"Mov Disord"},{"key":"478_CR73","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/nar\/gkn084","volume":"36","author":"J Grundemann","year":"2008","unstructured":"Grundemann J, Schlaudraff F, Haeckel O, Liss B (2008) Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson\u2019s disease. Nucleic Acids Res 36:e38","journal-title":"Nucleic Acids Res"},{"key":"478_CR74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(01)02772-X","volume":"914","author":"E Rockenstein","year":"2001","unstructured":"Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D, Masliah E (2001) Altered expression of the synuclein family mRNA in Lewy body and Alzheimer\u2019s disease. Brain Res 914:48\u201356","journal-title":"Brain Res"},{"key":"478_CR75","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/glia.22653","volume":"62","author":"YT Asi","year":"2014","unstructured":"Asi YT, Simpson JE, Heath PR, Wharton SB, Lees AJ, Revesz T, Houlden H, Holton JL (2014) Alpha-synuclein mRNA expression in oligodendrocytes in MSA. Glia 62:964\u2013970. doi: 10.1002\/glia.22653","journal-title":"Glia"},{"key":"478_CR76","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jalz.2015.05.011","volume":"11","author":"MW Lutz","year":"2015","unstructured":"Lutz MW, Saul R, Linnertz C, Glenn OC, Roses AD, Chiba-Falek O (2015) A cytosine-thymine (CT)-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer\u2019s disease and affects SNCA expression. Alzheimers Dement 11:1133\u20131143. doi: 10.1016\/j.jalz.2015.05.011","journal-title":"Alzheimers Dement"},{"key":"478_CR77","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/1531-8257(199905)14:3<417::AID-MDS1005>3.0.CO;2-X","volume":"14","author":"M Neystat","year":"1999","unstructured":"Neystat M, Lynch T, Przedborski S, Kholodilov N, Rzhetskaya M, Burke RE (1999) Alpha-synuclein expression in substantia nigra and cortex in Parkinson\u2019s disease. Mov Disord 14:417\u2013422","journal-title":"Mov Disord"},{"key":"478_CR78","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mds.10683","volume":"19","author":"AE Kingsbury","year":"2004","unstructured":"Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ (2004) Alteration in alpha-synuclein mRNA expression in Parkinson\u2019s disease. Mov Disord 19:162\u2013170","journal-title":"Mov Disord"},{"key":"478_CR79","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/mds.20391","volume":"20","author":"EK Tan","year":"2005","unstructured":"Tan EK, Chandran VR, Fook-Chong S, Shen H, Yew K, Teoh ML, Yuen Y, Zhao Y (2005) Alpha-synuclein mRNA expression in sporadic Parkinson\u2019s disease. Mov Disord 20:620\u2013623","journal-title":"Mov Disord"},{"key":"478_CR80","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","volume":"113","author":"PH Lee","year":"2006","unstructured":"Lee PH, Lee G, Park HJ, Bang OY, Joo IS, Huh K (2006) The plasma alpha-synuclein levels in patients with Parkinson\u2019s disease and multiple system atrophy. J Neural Transm (Vienna) 113:1435\u20131439. doi: 10.1007\/s00702-005-0427-9","journal-title":"J Neural Transm (Vienna)"},{"key":"478_CR81","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.expneurol.2006.12.006","volume":"204","author":"QX Li","year":"2007","unstructured":"Li QX, Mok SS, Laughton KM, McLean CA, Cappai R, Masters CL, Culvenor JG, Horne MK (2007) Plasma alpha-synuclein is decreased in subjects with Parkinson\u2019s disease. Exp Neurol 204:583\u2013588. doi: 10.1016\/j.expneurol.2006.12.006","journal-title":"Exp Neurol"},{"key":"478_CR82","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","volume":"480","author":"M Shi","year":"2010","unstructured":"Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J (2010) Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson\u2019s disease. Neurosci Lett 480:78\u201382. doi: 10.1016\/j.neulet.2010.06.009","journal-title":"Neurosci Lett"},{"key":"478_CR83","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","volume":"25","author":"Y Chu","year":"2007","unstructured":"Chu Y, Kordower JH (2007) Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson\u2019s disease? Neurobiol Dis 25:134\u2013149. doi: 10.1016\/j.nbd.2006.08.021","journal-title":"Neurobiol Dis"},{"key":"478_CR84","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/nm1210-1372b","volume":"16","author":"JA Obeso","year":"2010","unstructured":"Obeso JA (2010) Modeling clinical features of neurodegeneration. Nat Med 16:1372. doi: 10.1038\/nm1210-1372b","journal-title":"Nat Med"},{"key":"478_CR85","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrn3039","volume":"12","author":"TJ Collier","year":"2011","unstructured":"Collier TJ, Kanaan NM, Kordower JH (2011) Ageing as a primary risk factor for Parkinson\u2019s disease: evidence from studies of non-human primates. Nat Rev Neurosci 12:359\u2013366. doi: 10.1038\/nrn3039","journal-title":"Nat Rev Neurosci"},{"key":"478_CR86","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1111\/j.1460-9568.2008.06527.x","volume":"28","author":"TM Fountaine","year":"2008","unstructured":"Fountaine TM, Venda LL, Warrick N, Christian HC, Brundin P, Channon KM, Wade-Martins R (2008) The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons. Eur J Neurosci 28:2459\u20132473. doi: 10.1111\/j.1460-9568.2008.06527.x","journal-title":"Eur J Neurosci"},{"key":"478_CR87","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-3-19","volume":"3","author":"J Lewis","year":"2008","unstructured":"Lewis J, Melrose H, Bumcrot D, Hope A, Zehr C, Lincoln S, Braithwaite A, He Z, Ogholikhan S, Hinkle K, Kent C, Toudjarska I, Charisse K, Braich R, Pandey RK, Heckman M, Maraganore DM, Crook J, Farrer MJ (2008) In vivo silencing of alpha-synuclein using naked siRNA. Mol Neurodegener 3:19","journal-title":"Mol Neurodegener"},{"key":"478_CR88","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/mt.2010.115","volume":"18","author":"OS Gorbatyuk","year":"2010","unstructured":"Gorbatyuk OS, Li S, Nash K, Gorbatyuk M, Lewin AS, Sullivan LF, Mandel RJ, Chen W, Meyers C, Manfredsson FP, Muzyczka N (2010) In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration. Mol Ther J. Am Soc Gene Ther 18:1450\u20131457. doi: 10.1038\/mt.2010.115","journal-title":"Mol Ther J. Am Soc Gene Ther"},{"key":"478_CR89","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s11064-008-9599-7","volume":"33","author":"D Liu","year":"2008","unstructured":"Liu D, Jin L, Wang H, Zhao H, Zhao C, Duan C, Lu L, Wu B, Yu S, Chan P, Li Y, Yang H (2008) Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells. Neurochem Res 33:1401\u20131409. doi: 10.1007\/s11064-008-9599-7","journal-title":"Neurochem Res"},{"key":"478_CR90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2011.02.041","volume":"1386","author":"Y Han","year":"2011","unstructured":"Han Y, Khodr CE, Sapru MK, Pedapati J, Bohn MC (2011) A microRNA embedded AAV alpha-synuclein gene silencing vector for dopaminergic neurons. Brain Res 1386:15\u201324. doi: 10.1016\/j.brainres.2011.02.041","journal-title":"Brain Res"},{"key":"478_CR91","doi-asserted-by":"publisher","first-page":"e12122","DOI":"10.1371\/journal.pone.0012122","volume":"5","author":"AL McCormack","year":"2010","unstructured":"McCormack AL, Mak SK, Henderson JM, Bumcrot D, Farrer MJ, Di Monte DA (2010) Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigra. PLoS one 5:e12122. doi: 10.1371\/journal.pone.0012122","journal-title":"PLoS one"},{"key":"478_CR92","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1038\/mtna.2015.14","volume":"4","author":"M Takahashi","year":"2015","unstructured":"Takahashi M, Suzuki M, Fukuoka M, Fujikake N, Watanabe S, Murata M, Wada K, Nagai Y, Hohjoh H (2015) Normalization of overexpressed alpha-synuclein causing Parkinson\u2019s disease by a moderate gene silencing with RNA interference. Molecular Therapy Nucleic Acids 4:e241. doi: 10.1038\/mtna.2015.14","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"478_CR93","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.brainres.2011.04.036","volume":"1395","author":"CE Khodr","year":"2011","unstructured":"Khodr CE, Sapru MK, Pedapati J, Han Y, West NC, Kells AP, Bankiewicz KS, Bohn MC (2011) An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson\u2019s disease, but displays toxicity in dopamine neurons. Brain Res 1395:94\u2013107. doi: 10.1016\/j.brainres.2011.04.036","journal-title":"Brain Res"},{"key":"478_CR94","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/428655","volume":"76","author":"O Chiba-Falek","year":"2005","unstructured":"Chiba-Falek O, Kowalak JA, Smulson ME, Nussbaum RL (2005) Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene. Am J Hum Genet 76:478\u2013492","journal-title":"Am J Hum Genet"},{"key":"478_CR95","doi-asserted-by":"publisher","first-page":"10907","DOI":"10.1073\/pnas.0802437105","volume":"105","author":"CR Scherzer","year":"2008","unstructured":"Scherzer CR, Grass JA, Liao Z, Pepivani I, Zheng B, Eklund AC, Ney PA, Ng J, McGoldrick M, Mollenhauer B, Bresnick EH, Schlossmacher MG (2008) GATA transcription factors directly regulate the Parkinson\u2019s disease-linked gene alpha-synuclein. Proc Natl Acad Sci U S A 105:10907\u201310912. doi: 10.1073\/pnas.0802437105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"478_CR96","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1471-4159.2009.06250.x","volume":"110","author":"RL Clough","year":"2009","unstructured":"Clough RL, Dermentzaki G, Stefanis L (2009) Functional dissection of the alpha-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219. J Neurochem 110:1479\u20131490. doi: 10.1111\/j.1471-4159.2009.06250.x","journal-title":"J Neurochem"},{"key":"478_CR97","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2015.05.029","volume":"599","author":"S Brenner","year":"2015","unstructured":"Brenner S, Wersinger C, Gasser T (2015) Transcriptional regulation of the alpha-synuclein gene in human brain tissue. Neurosci Lett 599:140\u2013145. doi: 10.1016\/j.neulet.2015.05.029","journal-title":"Neurosci Lett"},{"key":"478_CR98","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1096\/fj.06-7111com","volume":"21","author":"RL Clough","year":"2007","unstructured":"Clough RL, Stefanis L (2007) A novel pathway for transcriptional regulation of alpha-synuclein. FASEB J 21:596\u2013607. doi: 10.1096\/fj.06-7111com","journal-title":"FASEB J"},{"key":"478_CR99","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1471-4159.2011.07199.x","volume":"117","author":"RL Clough","year":"2011","unstructured":"Clough RL, Dermentzaki G, Haritou M, Petsakou A, Stefanis L (2011) Regulation of alpha-synuclein expression in cultured cortical neurons. J Neurochem 117:275\u2013285. doi: 10.1111\/j.1471-4159.2011.07199.x","journal-title":"J Neurochem"},{"key":"478_CR100","doi-asserted-by":"publisher","first-page":"259","DOI":"10.12688\/f1000research.3281.2","volume":"3","author":"L Sterling","year":"2014","unstructured":"Sterling L, Walter M, Ting D, Schule B (2014) Discovery of functional non-coding conserved regions in the alpha-synuclein gene locus. F1000Res 3:259. doi: 10.12688\/f1000research.3281.2","journal-title":"F1000Res"},{"key":"478_CR101","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E (2010) Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 285:12726\u201312734. doi: 10.1074\/jbc.M109.086827","journal-title":"J Biol Chem"},{"key":"478_CR102","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","volume":"20","author":"E Minones-Moyano","year":"2011","unstructured":"Minones-Moyano E, Porta S, Escaramis G, Rabionet R, Iraola S, Kagerbauer B, Espinosa-Parrilla Y, Ferrer I, Estivill X, Marti E (2011) MicroRNA profiling of Parkinson\u2019s disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function. Hum Mol Genet 20:3067\u20133078. doi: 10.1093\/hmg\/ddr210","journal-title":"Hum Mol Genet"},{"key":"478_CR103","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.nbd.2014.05.030","volume":"69","author":"I Villar-Menendez","year":"2014","unstructured":"Villar-Menendez I, Porta S, Buira SP, Pereira-Veiga T, Diaz-Sanchez S, Albasanz JL, Ferrer I, Martin M, Barrachina M (2014) Increased striatal adenosine A2A receptor levels is an early event in Parkinson\u2019s disease-related pathology and it is potentially regulated by miR-34b. Neurobiol Dis 69:206\u2013214. doi: 10.1016\/j.nbd.2014.05.030","journal-title":"Neurobiol Dis"},{"key":"478_CR104","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.febslet.2014.12.014","volume":"589","author":"S Kabaria","year":"2015","unstructured":"Kabaria S, Choi DC, Chaudhuri AD, Mouradian MM, Junn E (2015) Inhibition of miR-34b and miR-34c enhances alpha-synuclein expression in Parkinson\u2019s disease. FEBS Lett 589:319\u2013325. doi: 10.1016\/j.febslet.2014.12.014","journal-title":"FEBS Lett"},{"key":"478_CR105","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.neurobiolaging.2014.10.042","volume":"36","author":"W Xu","year":"2015","unstructured":"Xu W, Tan L, Yu JT (2015) The link between the SNCA gene and parkinsonism. Neurobiol Aging 36:1505\u20131518. doi: 10.1016\/j.neurobiolaging.2014.10.042","journal-title":"Neurobiol Aging"},{"key":"478_CR106","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.freeradbiomed.2009.10.045","volume":"48","author":"SV Kalivendi","year":"2010","unstructured":"Kalivendi SV, Yedlapudi D, Hillard CJ, Kalyanaraman B (2010) Oxidants induce alternative splicing of alpha-synuclein: implications for Parkinson\u2019s disease. Free Radic Biol Med 48:377\u2013383. doi: 10.1016\/j.freeradbiomed.2009.10.045","journal-title":"Free Radic Biol Med"},{"key":"478_CR107","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10048-008-0124-6","volume":"9","author":"K Beyer","year":"2008","unstructured":"Beyer K, Domingo-Sabat M, Humbert J, Carrato C, Ferrer I, Ariza A (2008) Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease. Neurogenetics 9:163\u2013172","journal-title":"Neurogenetics"},{"key":"478_CR108","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00401-006-0104-6","volume":"112","author":"K Beyer","year":"2006","unstructured":"Beyer K (2006) Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers. Acta Neuropathol 112:237\u2013251","journal-title":"Acta Neuropathol"},{"key":"478_CR109","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1074\/jbc.M107045200","volume":"277","author":"HJ Lee","year":"2002","unstructured":"Lee HJ, Choi C, Lee SJ (2002) Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 277:671\u2013678","journal-title":"J Biol Chem"},{"key":"478_CR110","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2990.2004.00572.x","volume":"30","author":"K Beyer","year":"2004","unstructured":"Beyer K, Lao JI, Carrato C, Mate JL, Lopez D, Ferrer I, Ariza A (2004) Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies. Neuropathol Appl Neurobiol 30:601\u2013607. doi: 10.1111\/j.1365-2990.2004.00572.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"478_CR111","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/01.wnr.0000224773.66904.e7","volume":"17","author":"K Beyer","year":"2006","unstructured":"Beyer K, Humbert J, Ferrer A, Lao JI, Carrato C, Lopez D, Ferrer I, Ariza A (2006) Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease. Neuroreport 17:1327\u20131330. doi: 10.1097\/01.wnr.0000224773.66904.e7","journal-title":"Neuroreport"},{"key":"478_CR112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10048-007-0106-0","volume":"9","author":"K Beyer","year":"2008","unstructured":"Beyer K, Domingo-Sabat M, Lao JI, Carrato C, Ferrer I, Ariza A (2008) Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases. Neurogenetics 9:15\u201323","journal-title":"Neurogenetics"},{"key":"478_CR113","doi-asserted-by":"publisher","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","volume":"31","author":"D Ebrahimi-Fakhari","year":"2011","unstructured":"Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z, Rockenstein E, Masliah E, Hyman BT, McLean PJ, Unni VK (2011) Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein. J Neurosci 31:14508\u201314520. doi: 10.1523\/JNEUROSCI.1560-11.2011","journal-title":"J Neurosci"},{"key":"478_CR114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-3-642-56373-7_3","volume":"29","author":"WF Ward","year":"2002","unstructured":"Ward WF (2002) Protein degradation in the aging organism. Prog Mol Subcell Biol 29:35\u201342","journal-title":"Prog Mol Subcell Biol"},{"key":"478_CR115","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s12035-012-8341-2","volume":"47","author":"M Xilouri","year":"2013","unstructured":"Xilouri M, Brekk OR, Stefanis L (2013) Alpha-synuclein and protein degradation systems: a reciprocal relationship. Mol Neurobiol 47:537\u2013551. doi: 10.1007\/s12035-012-8341-2","journal-title":"Mol Neurobiol"},{"key":"478_CR116","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ana.410400212","volume":"40","author":"Y Xia","year":"1996","unstructured":"Xia Y, Rohan de Silva HA, Rosi BL, Yamaoka LH, Rimmler JB, Pericak-Vance MA, Roses AD, Chen X, Masliah E, DeTeresa R, Iwai A, Sundsmo M, Thomas RG, Hofstetter CR, Gregory E, Hansen LA, Katzman R, Thal LJ, Saitoh T (1996) Genetic studies in Alzheimer\u2019s disease with an NACP\/alpha-synuclein polymorphism. Ann Neurol 40:207\u2013215","journal-title":"Ann Neurol"},{"key":"478_CR117","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1101\/gr.165801","volume":"11","author":"JW Touchman","year":"2001","unstructured":"Touchman JW, Dehejia A, Chiba-Falek O, Cabin DE, Schwartz JR, Orrison BM, Polymeropoulos MH, Nussbaum RL (2001) Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element. Genome Res 11:78\u201386","journal-title":"Genome Res"},{"key":"478_CR118","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/hmg\/10.26.3101","volume":"10","author":"O Chiba-Falek","year":"2001","unstructured":"Chiba-Falek O, Nussbaum RL (2001) Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet 10:3101\u20133109","journal-title":"Hum Mol Genet"},{"key":"478_CR119","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1111\/ene.12694","volume":"22","author":"SM Goldman","year":"2015","unstructured":"Goldman SM, Umbach DM, Kamel F, Tanner CM (2015) Head injury, alpha-synuclein Rep1 and Parkinson\u2019s disease: a meta-analytic view of gene-environment interaction. Eur J Neurol 22:e75. doi: 10.1111\/ene.12694","journal-title":"Eur J Neurol"},{"key":"478_CR120","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/ajmg.b.30758","volume":"147B","author":"DM Kay","year":"2008","unstructured":"Kay DM, Factor SA, Samii A, Higgins DS, Griffith A, Roberts JW, Leis BC, Nutt JG, Montimurro JS, Keefe RG, Atkins AJ, Yearout D, Zabetian CP, Payami H (2008) Genetic association between alpha-synuclein and idiopathic Parkinson\u2019s disease. Am J Med Genet B Neuropsychiatr Genet 147B:1222\u20131230","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"478_CR121","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/hmg\/10.17.1847","volume":"10","author":"M Farrer","year":"2001","unstructured":"Farrer M, Maraganore DM, Lockhart P, Singleton A, Lesnick TG, de Andrade M, West A, de Silva R, Hardy J, Hernandez D (2001) Alpha-synuclein gene haplotypes are associated with Parkinson\u2019s disease. Hum Mol Genet 10:1847\u20131851","journal-title":"Hum Mol Genet"},{"key":"478_CR122","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jnnp.73.3.350","volume":"73","author":"I Mizuta","year":"2002","unstructured":"Mizuta I, Nishimura M, Mizuta E, Yamasaki S, Ohta M, Kuno S (2002) Meta-analysis of alpha synuclein\/NACP polymorphism in Parkinson\u2019s disease in Japan. J Neurol Neurosurg Psychiatry 73:350","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"478_CR123","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neulet.2004.10.078","volume":"375","author":"GD Mellick","year":"2005","unstructured":"Mellick GD, Maraganore DM, Silburn PA (2005) Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson\u2019s disease. Neurosci Lett 375:112\u2013116","journal-title":"Neurosci Lett"},{"key":"478_CR124","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1093\/hmg\/ddp265","volume":"18","author":"KD Cronin","year":"2009","unstructured":"Cronin KD, Ge D, Manninger P, Linnertz C, Rossoshek A, Orrison BM, Bernard DJ, El-Agnaf OM, Schlossmacher MG, Nussbaum RL, Chiba-Falek O (2009) Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain. Hum Mol Genet 18:3274\u20133285. doi: 10.1093\/hmg\/ddp265","journal-title":"Hum Mol Genet"},{"key":"478_CR125","doi-asserted-by":"publisher","first-page":"e7480","DOI":"10.1371\/journal.pone.0007480","volume":"4","author":"C Linnertz","year":"2009","unstructured":"Linnertz C, Saucier L, Ge D, Cronin KD, Burke JR, Browndyke JN, Hulette CM, Welsh-Bohmer KA, Chiba-Falek O (2009) Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues. PLoS one 4:e7480. doi: 10.1371\/journal.pone.0007480","journal-title":"PLoS one"},{"key":"478_CR126","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/jnr.21270","volume":"85","author":"K Beyer","year":"2007","unstructured":"Beyer K, Humbert J, Ferrer A, Lao JI, Latorre P, Lopez D, Tolosa E, Ferrer I, Ariza A (2007) A variable poly-T sequence modulates alpha-synuclein isoform expression and is associated with aging. J Neurosci Res 85:1538\u20131546. doi: 10.1002\/jnr.21270","journal-title":"J Neurosci Res"},{"key":"478_CR127","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10048-010-0263-4","volume":"12","author":"JJ McCarthy","year":"2011","unstructured":"McCarthy JJ, Linnertz C, Saucier L, Burke JR, Hulette CM, Welsh-Bohmer KA, Chiba-Falek O (2011) The effect of SNCA 3\u2032 region on the levels of SNCA-112 splicing variant. Neurogenetics 12:59\u201364. doi: 10.1007\/s10048-010-0263-4","journal-title":"Neurogenetics"},{"key":"478_CR128","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neulet.2009.06.034","volume":"461","author":"S Sotiriou","year":"2009","unstructured":"Sotiriou S, Gibney G, Baxevanis AD, Nussbaum RL (2009) A single nucleotide polymorphism in the 3\u2032UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease. Neurosci Lett 461:196\u2013201. doi: 10.1016\/j.neulet.2009.06.034","journal-title":"Neurosci Lett"},{"key":"478_CR129","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X","volume":"45","author":"R Kruger","year":"1999","unstructured":"Kruger R, Vieira-Saecker AM, Kuhn W, Berg D, Muller T, Kuhnl N, Fuchs GA, Storch A, Hungs M, Woitalla D, Przuntek H, Epplen JT, Schols L, Riess O (1999) Increased susceptibility to sporadic Parkinson\u2019s disease by a certain combined alpha-synuclein\/apolipoprotein E genotype. Ann Neurol 45:611\u2013617","journal-title":"Ann Neurol"},{"key":"478_CR130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00439-008-0466-z","volume":"123","author":"CC McCulloch","year":"2008","unstructured":"McCulloch CC, Kay DM, Factor SA, Samii A, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Montimurro JS, Zabetian CP, Payami H (2008) Exploring gene-environment interactions in Parkinson\u2019s disease. Hum Genet 123:257\u2013265","journal-title":"Hum Genet"},{"key":"478_CR131","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/acn3.231","volume":"2","author":"T Peuralinna","year":"2015","unstructured":"Peuralinna T, Myllykangas L, Oinas M, Nalls MA, Keage HA, Isoviita VM, Valori M, Polvikoski T, Paetau A, Sulkava R, Ince PG, Zaccai J, Brayne C, Traynor BJ, Hardy J, Singleton AB, Tienari PJ (2015) Genome-wide association study of neocortical Lewy-related pathology. Ann Clin Transl Neurol 2:920\u2013931. doi: 10.1002\/acn3.231","journal-title":"Ann Clin Transl Neurol"},{"key":"478_CR132","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13195-014-0073-2","volume":"6","author":"WS Kim","year":"2014","unstructured":"Kim WS, Kagedal K, Halliday GM (2014) Alpha-synuclein biology in Lewy body diseases. Alzheimer\u2019s Res Therapy 6:73. doi: 10.1186\/s13195-014-0073-2","journal-title":"Alzheimer\u2019s Res Therapy"},{"key":"478_CR133","doi-asserted-by":"publisher","first-page":"e0133776","DOI":"10.1371\/journal.pone.0133776","volume":"10","author":"Y Chen","year":"2015","unstructured":"Chen Y, Wei QQ, Ou R, Cao B, Chen X, Zhao B, Guo X, Yang Y, Chen K, Wu Y, Song W, Shang HF (2015) Genetic variants of SNCA are associated with susceptibility to Parkinson\u2019s disease but not amyotrophic lateral sclerosis or multiple system atrophy in a Chinese population. PLoS one 10:e0133776. doi: 10.1371\/journal.pone.0133776","journal-title":"PLoS one"},{"key":"478_CR134","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s13311-013-0211-8","volume":"10","author":"N Ammal Kaidery","year":"2013","unstructured":"Ammal Kaidery N, Tarannum S, Thomas B (2013) Epigenetic landscape of Parkinson\u2019s disease: emerging role in disease mechanisms and therapeutic modalities. Neurotherapeutics 10:698\u2013708. doi: 10.1007\/s13311-013-0211-8","journal-title":"Neurotherapeutics"},{"key":"478_CR135","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","volume":"30","author":"A Jowaed","year":"2010","unstructured":"Jowaed A, Schmitt I, Kaut O, Wullner U (2010) Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains. J Neurosci off J Soc Neurosci 30:6355\u20136359. doi: 10.1523\/JNEUROSCI.6119-09.2010","journal-title":"J Neurosci off J Soc Neurosci"},{"key":"478_CR136","doi-asserted-by":"publisher","first-page":"e15522","DOI":"10.1371\/journal.pone.0015522","volume":"5","author":"L Matsumoto","year":"2010","unstructured":"Matsumoto L, Takuma H, Tamaoka A, Kurisaki H, Date H, Tsuji S, Iwata A (2010) CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson\u2019s disease. PLoS one 5:e15522. doi: 10.1371\/journal.pone.0015522","journal-title":"PLoS one"},{"key":"478_CR137","doi-asserted-by":"publisher","first-page":"9031","DOI":"10.1074\/jbc.C110.212589","volume":"286","author":"P Desplats","year":"2011","unstructured":"Desplats P, Spencer B, Coffee E, Patel P, Michael S, Patrick C, Adame A, Rockenstein E, Masliah E (2011) Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J Biol Chem 286:9031\u20139037. doi: 10.1074\/jbc.C110.212589","journal-title":"J Biol Chem"},{"key":"478_CR138","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neulet.2014.03.076","volume":"569","author":"Y Song","year":"2014","unstructured":"Song Y, Ding H, Yang J, Lin Q, Xue J, Zhang Y, Chan P, Cai Y (2014) Pyrosequencing analysis of SNCA methylation levels in leukocytes from Parkinson\u2019s disease patients. Neurosci Lett 569:85\u201388. doi: 10.1016\/j.neulet.2014.03.076","journal-title":"Neurosci Lett"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-016-0478-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10048-016-0478-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-016-0478-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:01:07Z","timestamp":1559102467000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10048-016-0478-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":138,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1007\/s10048-016-0478-0","relation":{},"ISSN":["1364-6745","1364-6753"],"issn-type":[{"value":"1364-6745","type":"print"},{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]}}}